PMC:7784786 / 202-340 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7784786","sourcedb":"PMC","sourceid":"7784786","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7784786","text":" progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The antibody ha","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"24","span":{"begin":87,"end":90},"obj":"Gene"},{"id":"29","span":{"begin":81,"end":86},"obj":"Species"},{"id":"33","span":{"begin":29,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Gene:923"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Tax:9606"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000597346"},{"subj":"24","pred":"source","obj":"LitCovid-PubTator"},{"subj":"29","pred":"source","obj":"LitCovid-PubTator"},{"subj":"33","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":29,"end":122},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T4","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ecb593","default":true},{"id":"LitCovid-sentences","color":"#9b93ec"}]}]}}